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Abstract
Many people with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/
AIDS) in Namibia have access to antiretroviral drugs but some still use traditional medicines to
treat opportunistic infections and offset side-effects from antiretroviral medication. Namibia has a
rich biodiversity of indigenous plants that could contain novel anti-HIV agents. However, such
medicinal plants have not been identified and properly documented. Various ethnomedicines used
to treat HIV/AIDS opportunistic infections have not been scientifically validated for safety and
efficacy. These limitations are mostly attributable to the lack of collaboration between biomedical
scientists and traditional healers. This paper presents a five-step contextual model for initiating
collaboration with Namibian traditional healers in order that candidate plants that may contain
novel anti-HIV agents are identified, and traditional medicines used to treat HIV/AIDS opportunistic
infections are subjected to scientific validation. The model includes key structures and processes
used to initiate collaboration with traditional healers in Namibia; namely, the National Biosciences
Forum, a steering committee with the University of Namibia (UNAM) as the focal point, a study
tour to Zambia and South Africa where other collaborative frameworks were examined,
commemorations of the African Traditional Medicine Day (ATMD), and consultations with
stakeholders in north-eastern Namibia. Experiences from these structures and processes are
discussed. All traditional healers in north-eastern Namibia were willing to collaborate with UNAM
in order that their traditional medicines could be subjected to scientific validation. The current
study provides a framework for future collaboration with traditional healers and the selection of
candidate anti-HIV medicinal plants and ethnomedicines for scientific testing in Namibia.
Background
Namibia has a generalized Human Immunodeficiency
Virus/Acquired Immunodeficiency Syndrome (HIV/
AIDS) epidemic, with 17.8% of antenatal clinic attendees
being HIV positive [1]. With over 230,000 people, out of
a total population of about 2 million, living with HIV/
AIDS, Namibia is one of the top five HIV/AIDS-affected
countries in the world [2,3]. By March 2007, there were
about 41,000 Namibians on antiretroviral treatment
(ART) [4]. The number of people on ART increased to
about 70,000 by August 2009.
Despite this impressive progress, Chinsembu [5] cau-
tioned that Namibia's ART programme is like a candle in
the wind as it battles to glimmer against the inevitable
possibility of dying from another form of AIDS- 'Acquired
Income Deficiency Syndrome'. There are concerns that the
country's free public sector ART programme is not sustain-
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able due its heavy reliance on donor funds. Besides fund-
ing, access to treatment in Namibia will have to cross
many rivers including: lack of confidentiality, lack of bed
space, lack of transport to hospitals, shortages of qualified
health workers, long queues, the criterion of treatment
supporter, and side-effects now causing new forms of
stigma [5].
Many HIV-infected Namibians have access to antiretrovi-
ral drugs, but some still use traditional medicines to treat
opportunistic infections and offset side-effects from
antiretroviral medication. In the case of rural Namibian
communities, formal biomedical services are also hardly
accessible. Thus whilst the majority of Namibian HIV/
AIDS patients rely on the current ART programme, some
still have faith in traditional medicines. In general, HIV/
AIDS patients are vulnerable in their choice of treatments,
such that they can vacillate from conventional ART pro-
grammes to traditional healers and vice versa; they want
to have the best of both worlds.
The inclusion of traditional medicines in official HIV/
AIDS policy is an extremely sensitive and contentious
issue in Southern Africa, the epicenter of HIV/AIDS. It is
sensitive because traditional medicines can easily become
a scapegoat for denial and inertia to roll-out ART as was
the case during President Thabo Mbeki's South Africa. It is
also contentious because in many resource-poor settings
in Sub-Saharan Africa, government-sponsored ART pro-
grammes discourage the use of traditional medicines, fear-
ing that the efficacy of antiretroviral drugs may be
inhibited by traditional medicines, or that their interac-
tions could lead to toxicity [6]. Reliance on traditional
medicines can also lead to a discontinuation of ART ther-
apy [7]. Thus many African governments still have contra-
dictory attitudes towards traditional medicines for AIDS,
discouraging it within ART programmes, and supporting
it within their initiatives of public health and primary
health care.
Prior to the availability of free and cheaper generic antiret-
roviral drugs, the World Health Organization (WHO) rec-
ommended that traditional healers be included in
national responses to HIV/AIDS [8]. In this light, African
governments expressed a need for a concerted, systematic
and sustained effort at both local and regional levels to
support and validate African traditional medicines on sev-
eral fronts, including evaluation of traditional remedies,
spiritual aspects of healing, HIV prevention and care,
standardization of processing and packaging traditional
remedies, as well as protection of indigenous knowledge
and intellectual property rights [9]. The importance of
investing in the high growth sectors of biotechnology and
phytomedicine was also articulated in the founding docu-
ment of the New Partnership for Africa's Development
(NEPAD), and later adopted by the African Biosciences
Initiative [10,11].
To popularize this commitment, the Organization of Afri-
can Unity (African Union) Heads of State and Govern-
ment declared the period 2000-2010 as the Decade of
African Traditional Medicine. In addition, the Director
General of WHO, declared 31st August of every year as the
African Traditional Medicine Day (ATMD) [8]. Further to
these declarations, the Eastern and Southern Africa
Regional Initiative on Traditional Medicine and AIDS
convened a consultative meeting in May 2003 [8]. All
these initiatives demonstrate the need to mainstream and
institutionalize traditional medicine into the formal
health care system. Puckree and others [12] emphasized
that health care professionals need to be proactive in inte-
grating traditional healing with westernized medicines in
order to promote health for all.
Although there are a good number of reports on tradi-
tional uses of plants to treat various diseases, knowledge
on herbal remedies used to manage HIV/AIDS is scanty,
impressionistic and not well documented [13]. One
known exception is Tanzania, where a detailed ethnobo-
tanical study documented the status and use of traditional
medicines in the management of HIV/AIDS opportunistic
infections [14]. Besides the problem of lack of documen-
tation, two other barriers continue to circumvent the inte-
gration of traditional medicines with modern
conventional medicines.
The first barrier is that traditional remedies have neither
been rigorously evaluated nor properly standardized.
They are also poorly prepared, packaged and preserved.
These drawbacks limit the use of traditional medicines for
the treatment of HIV/AIDS [13]. The second obstacle
speaks to how collaboration between traditional healers
and biomedical scientists can be initiated, operational-
ized, and sustained. Here, the concern is how to initiate
collaboration between two health care systems that differ
in theory of disease causation and management [13].
In spite of the above dilemma, collaboration is essential,
given the changing epidemic of HIV and the dynamic rela-
tionship between the two health sectors [15]. Thus experts
recommend that health care providers must open lines of
communication with traditional healers [16]. However,
initiating collaboration is not as easy it appears to be from
the literature, and if it is to be meaningful, systematic
steps must be followed in order to arrive at sustainable
collaboration between traditional healers and biomedical
scientists [13]. Previous attempts at collaboration with the
traditional health care sector have evolved around organ-
izing traditional healers into national associations, train-
ing programmes for healers, and laboratory testing ofJournal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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herbs [17]. Kayombo and co-workers [13] found that
effective collaboration should involve signing Memo-
randa of Understanding (MOU) covering intentions, obli-
gations and mutual responsibilities of all parties. The
MOU should also outline how benefits ensuing from the
collaboration will be distributed [13].
There are renewed attempts to open communication with
traditional healers in Namibia. These efforts will help bio-
medical practitioners gain useful insights into the work of
traditional healers. However, this does not mean that tra-
ditional healers are now part of the country's strategy
against HIV/AIDS. The spirit to seek collaboration of tra-
ditional healers is not a point of departure from ART. In
fact, there are no reliable scientific data regarding the use
of traditional medicines for the management of HIV/AIDS
in Namibia. Within this prism of caution, it is clear that
the only way to improve the quality and prolong the life
of Namibian HIV/AIDS patients is through the use of
available antiretroviral drugs.
On the other hand, the current use of generic antiretrovi-
ral drugs still faces several challenges including, HIV
resistance, toxicity, limited availability, and lack of cura-
tive effect [18]. Thus it is important to search for novel
anti-HIV agents which can expand the current arsenal
against HIV. Natural sources, particularly plants, appear a
promising source of medicines for symptomatic treatment
of Sexually Transmitted Diseases (STDs) including AIDS
(see review by Vermani and Garg [19]). In the past two
decades, a substantial amount of research has been done
worldwide, and a lot more is in progress, to isolate anti-
HIV active leads from plants.
Indigenous knowledge [20], coupled with a history of safe
use and ethnopharmacological efficacy [18,19], present a
faster approach to discover new anti-HIV agents. This new
approach is now being called reverse pharmacology [20].
Following this approach, a novel class of integrase inhibi-
tors, the dicaffeoylquinic acids (DCQAs), was isolated
from medicinal plants in Bolivia [21,22]. Since Namibia
has a rich biodiversity and a long tradition of medicinal
use of plants, there is potential to isolate novel chemical
compounds that can inhibit key HIV enzymes. Such
plant-based compounds could improve the efficacy of
existing drugs and retard the emergence of drug-resistant
HIV [21].
Some Namibian traditional healers could be living librar-
ies or reservoirs of indigenous knowledge and insightful
experiences that could open new vistas in the identifica-
tion of local plants with novel anti-HIV activity. Such gen-
uine traditional healers should be carefully selected, on a
case-by-case basis, because some traditional healers are
charlatans. Given such a benefit of a doubt, some
Namibian traditional medicines could present possible
leads for the identification of novel anti-HIV compounds.
Despite the potential to isolate novel anti-HIV agents
from Namibian medicinal plants, there has been little
engagement of traditional healers by the scientific com-
munity. To-date, no collaborative effort between
Namibian healers and scientists has been initiated and no
agreements to work together are in place. As a result of this
lack of operative collaboration, bioprospecting for local
medicinal plants with novel anti-HIV compounds has not
been done, and traditional medicines used by healers to
treat HIV/AIDS opportunistic infections have not been
scientifically validated.
Responding to the compelling need for evidence regard-
ing traditional medicines, NEPAD and Southern African
Network for Biosciences (SANBio) launched a flagship
project to validate traditional medicines for the affordable
treatment of HIV/AIDS and opportunistic infections.
NEPAD/SANBio would like to replicate this flagship
project to many other countries. However, scientific
researchers in many countries have been unable to find
the entry point into the sphere of traditional medicines
because of the various institutional and intellectual prop-
erty rights' bottlenecks that impede access to traditional
healers and their medicines.
This article presents a five-step model of initiating collab-
oration with Namibian traditional healers so that local
plants and ethnomedicines that may contain novel anti-
HIV compounds are identified and subjected to scientific
validation. Further to the model, the article describes and
discusses experiences from the five steps or processes that
were used to initiate collaboration, namely the: (i)
National Biosciences Forum; (ii) multi-stakeholder steer-
ing committee with the University of Namibia (UNAM) as
the focal point; (iii) study tour to institutions in Zambia
and South Africa where validation of traditional medi-
cines for HIV/AIDS was being undertaken; (iv) commem-
oration of the ATMD; and (v) consultations with various
stakeholders in the project area.
Research Methodology
This study used a five-step research methodology:
1. In order to initiate research on traditional medicines,
the Ministry of Education's Directorate of Research, Sci-
ence and Technology (ME-DRST) organized a transparent
and participatory National Biosciences Forum (NBF) on
November 20, 2007. Local stakeholders including the
academia, government departments, and Non-Govern-
mental Organizations (NGOs) attended the NBF. Offi-
cials from NEPAD/SANBio and the Council for Scientific
and Industrial Research (CSIR) laboratories, Pretoria,Journal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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South Africa, also attended the forum, and presented key-
note papers on collaborative initiatives involving the val-
idation of ethnomedicines used by traditional healers to
treat HIV/AIDS.
2. The NBF formed a multi-stakeholder steering commit-
tee to spearhead the validation of traditional medicines in
Namibia. The NBF also unanimously elected UNAM as
focal point of the steering committee and mandated the
institution to initiate research on the validation of tradi-
tional medicines for affordable treatment of HIV/AIDS
and opportunistic infections in Namibia.
3. In July 2008, a one-week study tour was undertaken to
Zambia (Ministry of Health and Sondashi clinic), and to
the CSIR laboratories in Pretoria, South Africa. A co-chair-
person from the focal point of the steering committee and
the chairperson of the Namibia Traditional Healers Asso-
ciation conducted the study visit. The study tour was
important because the Ministry of Health in Zambia was
collaborating with CSIR laboratories in validating a herbal
formula used by Ludwig Sondashi, a traditional healer
from Zambia, to treat HIV/AIDS.
4. Commemorations of the ATMD allowed UNAM to gain
access to individual traditional healers and other stake-
holders. Two elaborate lines of communication led to the
successful relationship between the UNAM focal point
and the Ministry of Health. First, the Permanent Secretary
(PS) of the Ministry of Health, Windhoek, requested the
UNAM Pro-Vice Chancellor for Academic Affairs and
Research (PVC-AAR) to nominate a representative to sit
on the national committee organizing the commemora-
tion of the ATMD. The PVC-AAR then nominated the focal
point to represent UNAM on the ATMD national organiz-
ing committee. Second, the PS had also agreed to an invi-
tation by the PVC-AAR to nominate a Ministry of Health
representative to the steering committee.
5. Stakeholders in the study area (north-eastern Namibia)
were informed about the research. These included govern-
ment officials (regional health directors, hospital superin-
tendents, primary health care administrators, regional
health administrators, community forestry officers, tradi-
tional leaders, chairpersons of traditional healers' associa-
tions, and key informants such as teachers and church
leaders. Opinions of these stakeholders towards tradi-
tional healers were ascertained during unstructured inter-
views as recommended by Agar [23]. The stakeholders
were also requested to furnish for 'leads' to local tradi-
tional healers. Finally, an exploratory and descriptive case
study of traditional healers was conducted in four admin-
istrative regions of north-eastern Namibia: Kavango,
Omusati, Oshana, and Caprivi. Data collected during the
exploratory and descriptive case study are not included in
the present article.
Results
Five step model used to initiate collaboration with 
traditional healers in Namibia
Figure 1 presents the five-step contextual model used to
initiate collaboration with traditional healers in Namibia.
The flow chart starts with the NBF (step 1), the structure
that established the steering committee (step 2a) and
mandated UNAM as the focal point (step 2b), to spear-
head the selection of candidate anti-HIV medicinal plants
and validation of traditional medicines used to treat HIV/
AIDS and related opportunistic infections. The study tour
(step 3) enabled the steering committee and the focal
point to gain invaluable insights into various collabora-
tive frameworks with traditional healers, and the scientific
validation process. Through the organization and com-
memoration of the ATMD (step 4), and consultations
with stakeholders in north-eastern Namibia (step 5a),
UNAM made contacts with and gained access to tradi-
tional healers, who where then interviewed in an explora-
tory and descriptive case study (step 5b). All the
traditional healers were eager to subject their ethnomedi-
cines to scientific validation, and were willing to collabo-
rate with UNAM in that regard. This Chinsembu model
was successful in initiating collaboration between UNAM
and traditional healers in Namibia.
Experiences from the five distinct processes of the model
National Biosciences Forum
The NBF was the 'seed' administrative structure that estab-
lished a multi-stakeholder steering committee mandated
to guide research towards the validation of traditional
medicines for the treatment of HIV/AIDS and opportunis-
tic infections in Namibia. UNAM did not have a national
institutional mandate to study traditional medicines for
treatment of HIV/AIDS and opportunistic infections in
Namibia. Through the multi-stakeholder consensus and
mandate derived from the NBF, UNAM (Faculty of Sci-
ence) found an institutional entry point to commence
work on the validation of traditional medicines for HIV/
AIDS treatment.
Steering committee and UNAM focal point
The role of UNAM as the focal point was to call and chair
meetings of the steering committee, whose other mem-
bers were: Polytechnic of Namibia; Namibia Traditional
Healers Association; Ministry of Agriculture, Water and
Forestry (Directorates of Research and Forestry); ME-
DRST; Ministry of Health and Social Services; Namibia
Chamber of Commerce and Industry; Health Profession-
als Councils of Namibia; three NGOs namely, Namibia
Network of AIDS Service Organizations (NANASO), the
Regional Agricultural and Environment Initiatives Net-Journal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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Five step model for initiating collaboration with traditional healers in Namibia Figure 1
Five step model for initiating collaboration with traditional healers in Namibia.
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work-Africa (RAEIN-Africa), and the Centre for Research
Information Action in Africa- Southern African Develop-
ment and Consulting (CRIAA-SADC); National Botanical
Research Institute (NBRI), and the Indigenous Plant Task
Team (IPTT).
Steering committee meetings helped to gauge stakeholder
expectations and anxieties. For example, certain members
of the steering committee were against the idea of setting
up a national pharmacopeia of plants used to treat HIV/
AIDS and related opportunistic infections. They were also
critical of UNAM's linkages with NEPAD/SANBio and
CSIR. Such criticisms were often centred on the controver-
sial issues of biopiracy, intellectual property rights, and
benefit sharing. A study tour to Zambia and South Africa
was undertaken in order to find out how the two countries
had dealt with such sensitive issues.
Study tour to Zambia and South Africa
For a long time, many traditional healers in Zambia
claimed 'cures' for HIV/AIDS. However, these claims had
not been subjected to scientific validation. In November
2005, an open observational and exploratory clinical trial
to validate traditional medicines used to treat HIV/AIDS
started in Lusaka. The objective of the trial was to evaluate
for efficacy of the formulations, and to establish change in
the physical and clinical status of HIV positive volunteers.
Three herbal formulations (Sondashi, Mayeyanini, and
Mailasine) were tested in 12, 11 and 9 HIV-positive adult
volunteers, respectively. It was not known whether the
volunteers had previously been on antiretroviral treat-
ment. However, their CD4 counts were determined at the
onset of the trial. The formulations were also tested for
any spicing with conventional antiretroviral drugs. The
trial ended in April 2006.
Results of that trial showed that all the three formulations
had anti-HIV activity, as measured by an increase in CD4
counts and reduction in viral loads, and did not have sig-
nificant liver and renal toxicity (Patrick Chikusu, personal
communication). Of the three formulations, the Sondashi
formula was found to be the best candidate for further val-
idation. One of the volunteers in the clinical trial was
interviewed by the visiting Namibian researchers; he con-
firmed that the Sondashi formula increased his CD4
count and reduced the viral load. He also extolled how the
Sondashi formula had restored his health.
The Sondashi herbal formula was invented by Ludwig
Sondashi, a former government minister and constitu-
tional lawyer with a PhD. He had first used it to treat his
sick son. At that time, Dr. Sondashi tried several herbs but
his son died. He then combined four plants that he used
to treat relatives with HIV/AIDS. He discovered that the
herbs were treating HIV/AIDS-related opportunistic infec-
tions.
The Zambian researchers led by Patrick Chikusu recom-
mended that further studies of the Sondashi formula (SF-
2000) be carried out using a larger group of volunteers,
and for a longer period of time. To further validate the
Sondashi formulation, NEPAD/SANBio took the herbal
formulation for further tests at the CSIR laboratories in
Pretoria, South Africa. Isolation of novel anti-HIV agents
from SF-2000 is being undertaken at the CSIR.
CSIR had legal frameworks that guide collaboration with
indigenous knowledge holders and traditional healers,
including heads of agreements with clauses on commer-
cialization and benefit sharing, publications, patents, and
formation of databases. In South Africa, the government
issued a bioprospecting permit only when a benefit shar-
ing agreement was in place. Such benefits were usually
given to communities, led by trust committees formed by
traditional healers. CSIR entered into agreements with
trust committees, or with individual traditional healers,
provided any such trust committees were informed. Thus
the principle of prior informed consent was followed.
During bioprospecting, traditional healers were paid
money to offset costs incurred during plant collection.
Such payments did not constitute sale of plant materials,
otherwise traditional healers would forfeit future benefits.
Sample delivery notes were used whenever plant materials
were handed over to the CSIR. According to CSIR collab-
orative frameworks, a patent was a publication, and tradi-
tional healers were not part of the patent. However,
traditional healers were entitled to benefits before patent-
ing.
Validation of the Sondashi formula at the CSIR was a
unique challenge because the collaborative process
involved many stakeholders from another country- Zam-
bia. The process was also complicated by the trans-bound-
ary shipment of plant materials. A different model of
collaboration was therefore used to circumscribe these
challenges. A consortium of institutional stakeholders,
managed by a steering committee, which included a law-
yer, entered into different agreements such as the consor-
tium agreement encompassing all stakeholders,
memorandum of agreement with the individual tradi-
tional healer, and materials transfer agreement with the
government.
African Traditional Medicine Day
Commemoration of the sixth ATMD in August 2008 was
the first of its kind in Namibia. Meetings of the organizing
committee were held at the Ministry of Health headquar-
ters in Windhoek. The meetings provided an importantJournal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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forum for the chairpersons of the steering committee to
interact with traditional healers and other stakeholders.
Members of the organizing committee were informed
about the new initiative to validate traditional medicines
for the treatment of HIV/AIDS and opportunistic infec-
tions.
The ATMD also helped to create public awareness of tradi-
tional medicines in Namibia. Public awareness cam-
paigns were conducted through television, radio,
newspapers, exhibitions of traditional medicines, displays
of publications on traditional medicines, and releases of
press statements. Under the theme "the role of traditional
health practitioners in primary health care", celebrations
of the ATMD provided the public with a rare glimpse into
the work of traditional healers. Many traditional healers
also felt that they had an important contribution to public
health. Official commemorations of the sixth ATMD were
held in Windhoek, the capital city of Namibia, while
those for the seventh ATMD in August 2009 were held in
Rundu, Kavango region. During the Rundu celebrations,
traditional healers exhibited their ethnomedicines, and
explained to the public the medicinal properties of the
various plants. The author presented a keynote paper cov-
ering findings of the exploratory and descriptive case
study of traditional healers in Namibia. The presentation
was televised on the Namibia Broadcasting Corporation
main news bulletin of September 7, 2009.
Stakeholder opinions of traditional healers in north-eastern Namibia
Stakeholders in north-eastern Namibia had various opin-
ions about traditional healers in general, and validation of
ethnomedicines used for HIV/AIDS treatment, in particu-
lar. Health officials such as the regional health directors
and primary health care administrators were negative
about traditional healers. One primary health care official
stated that she "did not trust these people". However, 90%
of stakeholders indicated their willingness to work with
UNAM to validate traditional healers' ethnomedicines
because "it was necessary to throw out the bad herbs and
promote the good ones". They were also keen to learn
about the outcome of the scientific validation of the Son-
dashi formula from Zambia. Community leaders such as
headmen and regional health administrators were more
positive about traditional healers in their communities.
They formed the best entry points to traditional healers,
who were eager to collaborate with UNAM and other
stakeholders in order that their ethnomedicines could be
scientifically validated.
Discussion
King [24] reviewed the conceptual elements necessary to
initiate collaboration between traditional healers and bio-
medical scientists in the management of HIV/AIDS in
Africa. Several country-specific models of collaboration
between biomedical and traditional health practitioners
in the field of HIV/AIDS management were discussed.
Kayombo and others [13] scrutinized King's conceptual
elements of collaboration and examined their practical
appropriateness in initiating collaboration in Tanzania.
This study presents a collaborative model that works in
Namibia's context. Models for controlled clinical evalua-
tion of traditional medicines for HIV/AIDS treatment exist
[25] but such models do not adequately address the initial
but critical stages of collaboration between biomedical
scientists and traditional healers. The protocols pay more
attention to clinical practice than the administrative struc-
tures that precede the validation process. The current con-
textual model describes distinct administrative structures
and processes that addressed the unique challenges found
at the interface between biomedical science and tradi-
tional medicine in Namibia. This is important because
UNAIDS best practice models have shown that sensitivity
to the political, environmental, cultural and economic
contexts is crucial to the success of collaborative interven-
tions [26]. The model helps to establish collaboration
with traditional healers so that candidate plants that may
contain novel anti-HIV agents are identified and tradi-
tional medicines used to treat HIV/AIDS opportunistic
infections are subjected to scientific testing.
Lebeau [27] studied the practice of traditional medicine in
Namibia, but as early as 1993, WHO had already tried to
partner with traditional healers in the management of
HIV/AIDS [28]. By 1996, traditional healers were regis-
tered by the Traditional Healers Council of Namibia,
established in March 1996, under the Allied Health Serv-
ices Professions Act of 1993 (Act 20 of 1993). The Tradi-
tional Healers Council was mandated to register
traditional healers and instill professionalism in their
trade. In 2004, the Allied Health Services Professions Act
of 1993 was replaced by the Allied Health Professions Act
(Act no. 7 of 2004), and the Traditional Healers Council
was subsequently dissolved. A Traditional Healers Bill was
then proposed but it is still under discussion. These
dynamics have left many Namibian traditional healers in
a legal quagmire and lacuna.
However, the dissolution of the Traditional Healers
Council was not just a legal technicality or coincidence. It
had been a long time coming, as government authorities
were seemingly getting impatient with traditional healers
that claimed to cure HIV/AIDS, and turned the epidemic
into a cash-cow. This was no different to the "AIDS oppor-
tunism" and "AIDS entrepreneurship" described by Rich-
ter [29]. There were also public protests against media
reports of HIV-infected adults that had sex with minors,
ostensibly because they were instructed by their tradi-
tional healers that sex with virgins would cure HIV/AIDS
[30]. Namibian traditional healers had not only managedJournal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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to turn the HIV/AIDS epidemic into a profitable enterprise
but also a moral minefield. The practice of traditional
medicine in Namibia assumed a tarnished public image.
Research institutions willing to initiate collaboration with
traditional healers would therefore have to tread very care-
fully, because these developments brought stigma to gen-
uine traditional healers, who retreated into treating their
patients at night, and created flashpoints of conflict with
their biomedical counterparts. Richter [29] confirmed
that there was friction between biomedicine and ethnom-
edicine in South Africa, often because biomedical scien-
tists were frustrated with traditional healers for claiming
to cure HIV/AIDS, and failing to refer their HIV positive
clients to the hospital, not until their immune systems
had completely broken down.
Traditional healers were seen to be preventing the access
of HIV/AIDS patients to conventional antiretroviral drugs,
brought into the country under the United States of Amer-
ica President's Emergency Programme for AIDS Relief
(PEPFAR) and Global Fund. The work of traditional heal-
ers was seen as being antagonistic to the rollout of antiret-
roviral drugs; this would obviously invite the intervention
of government officials and donors, who are usually
defensive in the face of criticism [31]. Against this back-
ground, Namibian traditional healers treating HIV/AIDS-
related conditions were isolated, thus it was very difficult
to initiate collaboration with those that would have
wanted to subject their ethnomedicines to scientific vali-
dation.
It would appear, therefore, that the Traditional Healers
Council was abolished for five reasons: (a) charlatan tra-
ditional healers that claimed AIDS cures, (b) public out-
rage against traditional healers that encouraged sex with
minors as a cure for AIDS, (c) lack of referral of HIV/AIDS
patients to hospitals, (d) possible friction with donors
regarding conventional ART programmes, and (e) fears of
non-compliance to conventional ART programmes.
Despite the current legislative lacuna regarding Namibian
traditional health practitioners, the model presented in
this study forms a sympathetic and respectful effort to
engage with Namibian traditional healers.
There are other reasons that make the initiation of collab-
oration with traditional healers a very sensitive issue.
Namibia is the driest African country south of the Sahara.
Therefore, it is not surprising that traditional communi-
ties and authorities are concerned about the management
of the country's natural resources. Falk [32] stated that
customary norms control access to resources, limit their
extraction, regulate the technologies of resource use, and
prescribe clear consequences for non-compliant behav-
iour. The sustainable use of Namibia's biodiversity is also
enshrined in the country's constitution. Article 95 of the
Namibian constitution states that: "the state shall actively
promote and maintain the welfare of the people by adapt-
ing policies aimed at... the maintenance of ecosystems,
essential ecological processes and biological diversity of
Namibia and utilization of living natural resources on a
sustainable basis, for the benefit of all Namibians, both
present and future" [33].
Namibia is a diamondiferous country but biodiversity,
and medicinal plants in particular, are now considered to
be the country's 'green diamonds'. Ironically, Article 95 of
the Namibian constitution has not been translated into
subsidiary laws to govern bioprospecting, and access and
benefit sharing. Government has instituted the National
Biodiversity Programme (NBF), the IPTT, and the Interim
Plant Bioprospecting Council (IPBC), mandated by Cabi-
net to deal with matters of indigenous plants and knowl-
edge, genetic resources, access and benefit sharing (ABS).
A Bill on ABS has been drafted but technical questions
remain unanswered [34]. Even if UNAM had applied to
the Ministry of Environment for a research permit,
approval of such an application would have been proba-
bly stranded in the prevailing legislative vacuum.
Despite the lack of specific and enforceable legislation
related to bioprospecting and ABS, government has real-
ized the value of the country's medicinal plants. As was
well argued by Reihling [35], such a realization stems
from the fact that trade in medicinal plants forms a 'hid-
den economy' that supports self-dependent plant gather-
ers, street vendors and healers, and forms part of income
generating strategies of rural households. Yet Namibia is
also home to market-exchange high value medicinal
plants such as the Devil's claw. By 1981, Namibia (then
South West Africa as it was called under Apartheid South
African rule), was known to export 200 tons per year of
Devil's claw [36]. Exports of Devil's claw were estimated at
600 tons a year in 1998 [37], and in excess of 1000 tons
in 2002 [38]. Ever since Namibian plants such as the
Devil's claw and Hoodia cactus entered the speculative
marketplace of biocapital [35], the country's political
leadership has become alive to the intrigues of scientific
validation and commercialization of indigenous medici-
nal plants.
Speaking at a symposium on the Devil's claw in 2001,
Namibia's first President, H.E. Sam Nujoma, said: "I
believe that while scientific research is necessary to
improve the way in which our natural resources are
exploited...our people must not be completely dis-
owned... of resources that they have possessed for genera-
tions. It will be a sad day when the medicinal formulas of
Devil's claw are patented by big pharmaceutical compa-
nies and thereby become depleted and unavailable to theJournal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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natural owners of the resource" [37]. Still, such statements
have not helped to put money into the pockets of the local
people.
Despite the end of Apartheid in 1990, the country's indig-
enous people have not benefited from the lucrative
biotrade in the Devil's claw, whose sales in Germany
soared to 30 million Euros as of 2001 [39]. A purified
extract from the Devil's claw was patented by Finkelberg,
a leading Germany company [35], and as President Sam
Nujoma had feared, the originators of the plant were nei-
ther addressed through patent negotiations nor did they
benefit from the large commercial success of the drug in
Germany where it turned into the third most frequently
used natural drug of all [35]. A 50 gram extract of Devil's
claw in tablet form fetched 25 Euros in 2007 [35] but
Namibian gatherers were paid 30-40 cents per kilogram of
dried tubers [40].
The case of the Devil's claw demonstrates that Namibians
have had little benefit from bioprospecting and commer-
cialization of their medicinal plants. It is within this prism
of economic dispossession that the entry point for
research into traditional medicines in Namibia was con-
fronted by moral and economic persuasions. Thus the sci-
entific validation of traditional medicines used for HIV/
AIDS had to be initiated in a very responsible and trans-
parent manner. There was a looming danger that UNAM
researchers would be seen to be mediating and colluding
with the interests of foreign commercial entities and capi-
tal. To avoid such pitfalls, UNAM had to tread carefully. It
was important for UNAM to strike an understanding with
capable authorizing institutions, thus the NBF provided a
transparent mechanism because it brought together all
stakeholders from government ministries, watchdog insti-
tutions such as IPBC and IPTT, academia, and NGOs. Else-
where, the role of NGOs was found to be crucial in
determining the success or failure of collaboration
[41,42].
For ethical reasons, officials from the IPBC were not part
of the steering committee. In meetings of the steering
committee, it became apparent that issues of intellectual
property rights, indigenous knowledge, ownership, bene-
fit sharing, biopiracy, trade secrets, materials transfer and
confidentiality contracts would cloud, and if not properly
handled, scuttle UNAM's efforts to collaborate with tradi-
tional healers in order to identify plants with novel anti-
HIV compounds, or validate ethnomedicines used to treat
HIV/AIDS opportunistic infections. There were questions
about UNAM's links with the CSIR, which had previously
patented P57, the active ingredient from Hoodia  [35].
Later, CSIR granted a license to exploit the patent to Phy-
topharm, a UK company [35]. In 2003, an ABS contract
granted the San people 6% share of the financial benefits
received by the CSIR from its private partners. However, it
is believed that the Hoodia ABS contract had not benefit-
ted the Namibian San [34].
While UNAM may have genuine interests in pursuing col-
laborations that could lead to the development of novel
anti-HIV medicines for the public good, Chokshi [43] in
the United States of America described cases where Uni-
versities which owned patents for antiretroviral drugs (sta-
vudine, emtricitabine, and tenofovir) had sold the
intellectual property rights for the medicines to private
pharmaceutical industries. The steering committee also
agreed to set up a Namibian pharmacopeia of traditional
plants used to treat HIV/AIDS and related opportunistic
infections. This would help preserve knowledge about
prospective ethnomedicines and indigenous plants with
novel anti-HIV activity. This is vital given that most heal-
ers were old and dying with their libraries of knowledge.
Similar documentation efforts were conducted in Tanza-
nia [14], though the idea to create a database or to publish
such data in the public domain remains a contentious
issue.
Namibian traditional healers and the chairperson of their
association were not present at the NBF. However, since
chairpersons of traditional healers' associations are
important gatekeepers, it was noted that the success of the
Namibian validation initiative would largely depend on
the strategic engagement of the Namibian Traditional
Healers Association. It was envisaged that collaboration
with Namibian traditional healers would depend on how
tactfully the steering committee engages with the chairper-
son of the Namibian Traditional Healers' Association.
Given that initiation of collaboration was a new effort in
Namibia, a lot of suspicions were bound to cloud the
process. Therefore, it was clear that a process of buy-in,
confidence building and learning would have to be car-
ried out before traditional healers agree to collaborate in
the identification of anti-HIV medicinal plants or the sci-
entific testing of their traditional herbal formulations.
The sensitization, fact-finding and familiarization study
tour to Zambia and South Africa by the co-chairperson of
the steering committee and the chairperson of the
Namibian Traditional Healers Association helped to
achieve the above objectives and set the stage for collabo-
ration. During the visit, the Namibian team obtained first-
hand information from the various stakeholders in Zam-
bia and CSIR. By learning what their Zambian counter-
parts had done, the Namibian Traditional Healers'
Association developed the confidence to initiate collabo-
ration with UNAM. The study visit helped to dispel mis-
trust and open a new chapter of collaboration to work
towards a mutual goal.Journal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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In Tanzania, researchers found that leaders of traditional
healers' associations appeared to be important gatekeep-
ers that can open or close the door to other healers willing
to collaborate with biomedical scientists [13]. Such lead-
ers of traditional healers often have reservations based on
questions surrounding the sharing of benefits from the
intended collaboration. Kayombo and co-workers [13]
are unequivocal on the point that leaders of traditional
healers' associations and other influential opinion leaders
are gateways to traditional healers, and thus the need to
treat them very carefully lest one cannot access genuine
traditional healers for collaboration. It is important that
consultations with leaders of traditional healers' associa-
tions should cultivate trust, confidence and respect. In
reality, the process to bring traditional healers on board
can be arduous and long. While the collaborative frame-
work from Tanzania provides useful lessons, there exist
unique challenges in every country.
Apart from informing the collaborative process in
Namibia, the study tour also shed light on the importance
of co-existence between traditional and conventional
health care. For example, the success of the open observa-
tional and exploratory clinical trial in Zambia was attrib-
uted to the joint collaborative effort arising from the good
working relationship with traditional healers [44]. The
good working relationship was a deliberate initiative from
government, which made the chairperson of Traditional
Health Practitioners' Association of Zambia (THPAZ)
become a member of the Sector Advisory Group (which
monitors health sector activities in Zambia), the tradi-
tional medicine research committee, and the Central
Board of Health. The involvement of traditional healers'
associations into mainstream health sector planning and
implementation helped to create trust, an important
ingredient which formed the cornerstone of the collabora-
tion between traditional healers and biomedical scientists
in Zambia. The clinical trial was also guided by a clear
MOU which dealt with issues of intellectual property
rights and benefit sharing.
Further, the sustainability of the collaboration in validat-
ing the SF-2000 herbal formulation was also underlined
by the fact that in Zambia, the Ministry of Health had
made tremendous progress in integrating traditional med-
icines into the health care delivery system. Health care was
delivered in a parallel approach, with traditional and con-
ventional medicines running side by side. Traditional
healers were allowed to operate their own clinics. Thus,
although conventional antiretroviral drugs were the
standard form of HIV/AIDS treatment, the government
did not take the use of traditional medicines to be in con-
flict. However, the interactive effects of combining west-
ern and traditional medicines have not been investigated.
For example, it was not clear whether promotion of tradi-
tional medicines for HIV/AIDS would reduce adherence
to and efficacy of conventional ART. Government was also
cautious of dubious traditional healers that claimed to
cure HIV/AIDS. A fake cure for AIDS called Tetrasil was
marketed by a Zambian newspaper editor in conjunction
with a United States of America AIDS denialist. Tetrasil
was later found to be a pesticide used to clean swimming
pools [45].
Therefore, the Ministry of Health regulated all research
into traditional medicines in Zambia. To that end, govern-
ment in January 2008 produced guidelines for research in
traditional medicines [46]. The guidelines were adapted
from those of the WHO. Further, the Ministry of Health
devised the Traditional Medicine Practice Council Bill,
and the Traditional Healers Practitioners Policy. These
instruments were aimed at regulating the practice of indi-
vidual traditional healers, and the various traditional
healers' associations, notably the Traditional Health Prac-
titioners' Association of Zambia, Zambia National Coun-
cil of 'Ngangas', and the Zambia Herbalist United
Organization.
At the CSIR, the Biosciences Research Programme was
involved in bioprospecting and drug discovery. The pro-
gramme was premised on a theoretical framework linking
biodiversity, science and indigenous knowledge, an
important ingredient known to accelerate drug discovery
through reverse pharmacology [20]. Indigenous knowl-
edge was found to reduce the timeframe, from therapeutic
concept to phase I clinical trial, from 15 to 3 years. The
CSIR had state-of-the-art scientific equipment for the
identification of novel anti-HIV compounds and for sci-
entific validation of traditional medicines. These included
a spray drier used to make crude herbal extracts following
the principles of good manufacturing practice. The study
tour therefore helped the Namibian visitors to appreciate
the scientific and technical realities of the validation proc-
ess, and that it was expensive. A similar study tour to Gha-
naian institutions was undertaken by researchers of the
Malawian steering/technical committee that begun work
on traditional medicines [47].
In my contextual collaborative model, the fourth process
involves celebrations of the African Traditional Medicine
Day. This process is a strong link that helps to popularize
the use of traditional medicines, apart from changing the
public image of traditional healers. The celebrations allow
interactions among government and WHO officials, tradi-
tional healers and the steering committee. Thus commem-
orations of the ATMD form a unique gateway to
traditional healers. This is important because it is a sign
that government is changing its negative attitude towards
traditional healers. The recognition of traditional healersJournal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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will also leverage pressure on Parliament to enact the law
on traditional medicine.
Participation of the stakeholders is critical to the owner-
ship of the whole process of validation of traditional med-
icines. Hence the research team had to explain the project
to local stakeholders. We found that traditional leaders
were a very useful lead to traditional healers in their com-
munities. The involvement of community leaders also
gave the researchers the confidence that they were dealing
with genuine traditional healers. Since traditional leaders
command the respect of their subjects, it was very easy for
traditional healers to open up to the research team in the
company of their community leaders. In Tanzania, studies
have shown that community leaders are important in
selecting competent and trustworthy traditional healers
for collaboration [13].
On the other hand, health officials were skeptical about
traditional medicines. They only began to soften their
stance upon being told by the research team that most
pharmaceutical drugs were actually derived from indige-
nous plants and knowledge. Except for the Chief Health
Programme Administrator in Rundu, and the Regional
HIV/AIDS Director in Katima Mulilo, most health officials
did not know any traditional healers in their communi-
ties, hence they were not a good entry point to traditional
healers. The negative attitude of health officials in north-
eastern Namibia is not conducive for sustainable collabo-
ration. Western trained officials, especially medical doc-
tors, seem to downplay the role of traditional healers [13].
This shows that despite the new spirit to collaborate with
traditional healers, there is still need for educational pro-
grammes to change the mindset of health officials in
north-eastern Namibia.
The attitude of these skeptical health officials can be
explained by the fact that the work of traditional healers is
not watched by a professional body. The training of tradi-
tional healers and the quality of their treatment are not
professionally controlled. Further, the work of diviners is
not easy to comprehend. While the work of herbalists is
much easier to understand since they select and apply
plant remedies, the work of diviners that diagnose dis-
eases using the 'ndaula' (beads) or those that deal with
'mulaleka' borders on special spiritual powers sometimes
called witchcraft. 'Mulaleka' is a sexual practice founded
in witchcraft. It is believed that someone can have sex by
remote, with someone that lives in another place, often
without consent. 'Mulaleka' was originally meant to assist
men to have sex with their wives that lived in faraway
places, especially husbands that had immigrated to cities
in search of jobs. However, the practice was now widely
used by men to engage in forced sexual intercourse with
women that they admired but have not consented to their
sexual proposals. Women who refused sexual proposals
from men often became victims of 'mulaleka'. Sometimes
older men also engaged in 'mulaleka' with younger
women and girls. It is widely believed that HIV-infected
men that practice 'mulaleka' also spread AIDS. Traditional
healers in the Caprivi region treated women to protect
them from 'mulaleka'. Herbs were applied in wounds
after bleeding patients around the waist. Plant roots were
also put under the pillow during sleep to protect would-
be victims of 'mulaleka'.
In the Caprivi region, the distinction between herbalists
and diviners has become blurred. Many traditional heal-
ers are both herbalists and diviners, treating the patient's
physical and spiritual needs. With an incurable condition
like AIDS, the spiritual aspects of treatment could be very
important [29]. Yet, to many health officials, it is the
diviners that make the profession of traditional medicine
look very suspicious and bogus. This is especially so
because, during Apartheid rule, the work of diviners was
prohibited under the Witchcraft Suppression Act of 1957
and the Witchcraft Suppression Amendment Act of 1970.
It seems that the mindset of Namibian biomedical practi-
tioners and society that resent traditional healers is still
stuck in the past laws of Apartheid.
Since traditional healers are the first point of call for many
patients in north-eastern Namibia, it is important that
both traditional healers and western trained health offi-
cials find common ground of collaboration. Synergy
between western trained doctors and traditional healers
will improve health care delivery in Namibia. For exam-
ple, traditional healers could learn best practices from
western trained doctors; this could help reduce infections.
In South Africa, it was found that traditional healers had
a crucial role to play in building the health care system,
including strengthening and supporting national
responses to HIV/AIDS [29]. Indeed, many trained doc-
tors now recognize traditional healers as potential allies in
the fight against HIV/AIDS [48].
Many traditional healers were willing to collaborate with
biomedical practitioners, with a view of subjecting their
ethnomedicines to scientific validation. However, their
eagerness to collaborate should be taken cautiously, as it
could be driven by commercial motives and the desire for
recognition and reputation. Already, there are complaints
that traditional healers are charging exorbitant fees for
their services. During the ATMD celebrations, a traditional
leader (Hompa) in Rundu, Kavango region, castigated tra-
ditional healers who demand cows from dying patients.
Profit-seeking motives and untrustworthiness of tradi-
tional healers could jeopardize future collaboration with
biomedical scientists.Journal of Ethnobiology and Ethnomedicine 2009, 5:30 http://www.ethnobiomed.com/content/5/1/30
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Conclusion
The model presented in this study shows that deliberate
steps can initiate collaboration between biomedical
researchers and traditional healers. In settings where there
is no legislation on bioprospecting and benefit sharing,
and where research institutions have no prior national
mandate to initiate work on scientific validation of tradi-
tional medicines, participatory forums of stakeholders,
including potential authorizing bodies and government
watchdog committees, should be constituted to ensure a
transparent and responsible research ethic. In this study,
the National Biosciences Forum created a transparent
entry point for UNAM to initiate collaborative efforts
towards validation of traditional medicines used for HIV/
AIDS treatment. To further enhance transparency, a steer-
ing committee of stakeholders can guide initiation of col-
laboration with traditional healers. Members of such a
steering committee should be willing to accept criticisms
from one another, and learn from other countries. Scien-
tific validation of traditional medicines is not a cheap
process. Therefore, research institutions from other coun-
tries should form part of the collaborating consortium,
provided specific legal agreements are in place. Fears of
biopiracy and inequitable sharing of benefits should not
overwhelm the genuineness and urgency of collaborative
attempts to scientifically validate traditional medicines
for the greater public good. Local avenues that enhance
interaction between traditional healers and biomedical
scientists should also be exploited. Such interactions will
largely depend on the strategic engagement of stakehold-
ers by the research institution. Community leaders, not
health officials, were found to be important gateways to
traditional healers. Initialization of collaboration with
traditional healers will enable biomedical scientists to
identify indigenous plants that appear to be promising
sources of medicines for symptomatic treatment of STDs
including AIDS. It will also lead to the scientific testing of
various ethnomedicines that traditional healers apply.
The five-step model is therefore a preliminary but impor-
tant prerequisite to the next aspect of the project: identifi-
cation of candidate plants and scientific testing of
traditional medicines in Namibia.
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